Patient & Survivor Care
Conference Coverage
Therapy ups breast cancer survivors’ cardiac risks
WASHINGTON – Anthracycline-based chemotherapy, anti-HER2 agents, and radiation all increase the risk for subsequent heart disease in breast cancer...
From the Journals
Cloud of inconsistency hangs over cannabis data
Number of medical cannabis users is up more than 10-fold since 2009, available data show.
Latest News
HHS effort aims to end new HIV cases within 10 years
WASHINGTON – “HIV has cost America too much for too long.”
Conference Coverage
Immunotherapy’s cardiac effects require early monitoring, management
Immune checkpoint inhibitors and chimeric antigen receptor T cells can be highly effective against cancer, but can also harm the heart and...
From the Journals
Clinical relevance of tamoxifen pharmacogenetics in question
Investigators found no significant association between endoxifen concentrations or CYP2D6 genotyping and relapse-free survival in patients with...
Feature
Guardian angel or watchdog? Pills of capecitabine contain sensors
Whether that’s a good thing or bad thing depends on who you talk to, but patients do seem more likely to take their medications if a sensor is on...
Hard Questions
Aftermath
It was Marty who showed me, early in my career, what happens after leukemia. I frequently see related issues in my patients now, and I credit...
Found in Translation
#Patients looking for #clinicaltrials
Crowdsourcing cancer research has a powerful ally in social media.
From the Journals
HBV, HCV, HIV testing of new cancer patients advised
Many patients with newly diagnosed cancers were unaware of their infection status, and some had no known risk factors.
From the Journals
Checkpoint inhibitors linked to rare, but serious immune-related side effects
The study breaks down the hematological immune-related side effects of checkpoint inhibitors.
Latest News
Soy didn’t up all-cause mortality in breast cancer survivors
The ongoing study tracks with previous work showing no risk from dietary soy.